When physical therapy and drugs fail to relieve back or neck pain, patients often turn to spinal fusion surgery as a last resort, but two new studies show that in certain situations, especially when several discs are involved, artificial disc replacement may give better long-term results at lower cost.
If you’re seeking an expert to discuss the increased public demand for potassium iodide in the wake of response to nuclear reactor problems in Japan, Glenn Braunstein, M.D., is available for interviews. Dr. Braunstein is Chair of the Department of Medicine and director of the Thyroid Cancer Center at Cedars-Sinai Medical Center, and is an experienced on-air and print interview.
Thanks to a grant from the George Hoag Family Foundation, Cedars-Sinai Medical Center’s COACH for Kids and Their Families® program will be able to expand healthcare services to more homeless children living in transitional shelters in Greater Los Angeles.
The Cedars-Sinai Heart Institute and Comprehensive Transplant Center performed the most adult heart transplants of any U.S. medical center in 2010, according to government statistics released today.
Armando E. Giuliano, M.D., internationally known for his research and clinical expertise in breast cancer, is joining Cedars-Sinai Medical Center as executive vice chair of surgery for surgical oncology. Giuliano will also serve in leadership roles at Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute: Along with pioneering surgeon Edward H. Phillips, M.D., Giuliano will be co-director of the Saul and Joyce Brandman Breast Center – a Project of the Women’s Guild; he will also serve as the institute’s associate director for surgical oncology.
John Gordon Harold, M.D., MACC, MACP, FCCP, FAHA, a past Chief of Staff of Cedars-Sinai Medical Center, has been named vice president of the American College of Cardiology. Harold’s term as one of the top officers of the 39,000-member group begins in April 2011 and his elevation to this post puts him on track to become president of the organization at the College’s 2013 annual meeting in San Francisco.
Patrick Lyden, M.D., a natoinally recognized stroke expert and chairman of the Cedars-Sinai Medical Center Department of Neurology, is available to discuss Aphasia, stroke and related neurological conditions.
Brain surgery takes much more skill than properly placing sutures in a foam skull, but aspiring doctors have to start somewhere, as 140 seventh- and eighth-grade students will learn at the annual “Brainworks” event at Cedars-Sinai Medical Center on Friday, Feb. 18. Cedars-Sinai’s program seeks to encourage early interest in neuroscience.
Whether or not you’re fond of Indian, Southeast Asian and Middle Eastern food, stroke researchers at Cedars-Sinai Medical Center think you may become a fan of one of their key spices. The scientists created a new molecule from curcumin, a chemical component of the golden-colored spice turmeric, and found in laboratory experiments that it affects mechanisms that protect and help regenerate brain cells after stroke.
A team of scientists from the Cedars-Sinai Regenerative Medicine Institute has been awarded a $1.9 million grant from the California Institute for Regenerative Medicine to fund development of a new technique to aid pharmaceutical discoveries for specific diseases. Additionally, another team from the Cedars-Sinai Department of Surgery will share a $1.5 million grant with a medical technology company aiming to develop a new imaging system.
The Western Society of Clinical Investigation has honored David L. Rimoin, M.D., Ph.D., director of the Cedars-Sinai Medical Genetics Institute, with its 2011 Mayo Soley Award for lifetime achievement in medical research and mentorship.
Richard V. Riggs, M.D., Medical Director and Chairman of Physical Medicine and Rehabilitation at Cedars-Sinai Medical Center in Los Angeles, is available to discuss rehabilitation after gunshot and other traumatic brain injuries.
Parkinson’s disease symptoms begin subtly and worsen as damage to certain brain cells continues. But an electrical stimulation device implanted deep in the brain, along with medications, may provide some control of symptoms such as shaking, stiffness, and loss of muscle control. But what happens if the drugs are stopped and the device is switched off after five years? Are the symptoms far worse than they were to start, as might be expected ? Surprisingly, no, says neurologist Michele Tagliati, M.D..
Keith L. Black, M.D., Chairman and Professor of Neurosurgery at Cedars-Sinai Medical Center in Los Angeles, is available to discuss gunshot and other traumatic brain injuries. He is an outstanding interview with extensive national interview experience -- both live on-air and via telephone. To arrange interviews, please contact Sandy Van at 808-526-1708 or 1-800-880-2397.
A ground-breaking antibiotic therapy developed at Cedars-Sinai Medical Center is the first potential drug treatment to provide irritable bowel syndrome patients with long-lasting relief of their symptoms even after they stop taking the medication, according to a study published in the Jan. 6 issue of the New England Journal of Medicine.
Laurie Harms, Los Angeles, feared she’d never hold her infant daughter, Sky, again. A devastating and extremely rare bone-eroding disease – Gorham-Stout syndrome – had left the 31-year-old crumpled in a hospital bed – her neck broken, arms limp and useless, and voice muted by tubes. Thanks to a young neurosurgeon who performed a "last resort" spinal fusion surgery at Cedars-Sinai she will be able to cuddle Baby Sky this holiday season.
The largest clinical trial of therapeutic brain cooling (hypothermia) after stroke has launched, led by researchers at the University of California, San Diego, the University of Texas Health Science Center at Houston, and at Cedars-Sinai Medical Center in Los Angeles. This study looks at whether hypothermia can safely be used in elderly stroke patients.
As the New Year draws closer, millions will renew their annual resolutions to get fit and many will turn to personal trainers to help them achieve their health goals. But how will they choose the trainer best suited to their needs? Alexis Peraino, M.D., a physician at the Cedars-Sinai Center for Weight Loss who also has a degree in exercise physiology, is uniquely qualified to offer advice on this question, as she selects the personal trainers for inclusion on the center’s referral list.
Burbank resident and liver transplant recipient Monica O’Brien has been chosen to ride the Donate Life float in the 2011Rose Parade in Pasadena on New Year’s Day. The 33-year-old, who underwent life-saving surgery at Cedars-Sinai Medical Center, will be one of 30 transplant candidates, recipients and donors greeting a million spectators, 52 million U.S. TV viewers and audiences worldwide.
Sessions on Wednesday, Nov. 17 also cover heart failure and changes on EKGs that may predict sudden cardiac death.
Eduardo Marbán, M.D., one of the most prominent cardiac stem cell researchers, will describe the latest advances during the event that begins at 1 p.m. Tuesday, Nov. 16.
Employing new drug-engineering technology that is part of an advanced science called nanomedicine, a Cedars-Sinai research team has created a “nanobioconjugate” drug that may be given by intravenous injection and carried in the blood to target the brain tumor. It is engineered to specifically permeate the tumor cell wall, entering endosomes, mobile compartments within cells.
Thanks to its community of dedicated donors, Cedars-Sinai Medical Center ended a five-year fundraising campaign with $357 million to invest in innovative research in specialty areas ranging from cancer to cardiac care, women’s health to pediatrics, pulmonary care to surgery and transplantation, and neuroscience to regenerative medicine.
For the first time in months, Laurie Harms is able to pick up and cuddle her baby girl. The young mother has a devastating and very rare bone-eroding disease – called Gorham-Stout syndrome – it is so rare that only 200 cases of it have been documented worldwide. Four neurosurgeons had already given up on her before she was referred last March to Cedars- Sinai Medical Center where she underwent a complex and innovative "last resort" spinal fusion surgery.
Neighborhood barbers, by conducting a monitoring, education and physician-referral program, can help their African-American customers better control high blood pressure problems that pose special health risks for them, a new study from the Cedars-Sinai Heart Institute shows.
A team of physicians and scientists from the Cedars-Sinai Regenerative Medicine Institute and Department of Surgery, led by Dan Gazit, DMD, PhD has been awarded a three-year $1.9 million grant from the California stem cell agency to fund research leading to clinical trials for what could become the first biological treatment for the most common type of bone fracture in osteoporosis patients.
Patients around the world who undergo advanced heart imaging studies benefit from the research and innovation of Daniel S. Berman, M.D., chief of cardiac imaging at the Cedars-Sinai Heart Institute and Cedars-Sinai’s S. Mark Taper Foundation Imaging Center. On Monday, Oct. 18, Cedars-Sinai’s medical staff recognized Berman’s achievements and influence, awarding him its highest honor, the Pioneer in Medicine Award.
Some of man’s best friends are wagging their tails – literally -- thanks to human research on a new type of surgical imaging device being pioneered at Cedars-Sinai Medical Center. Nine dogs that would have died of canine Cushing’s disease are alive and barking today, and even one cat has been given a new lease on one of its nine lives.
Sarah J. Kilpatrick, M.D., Ph.D., a nationally renowned expert in maternal-fetal medicine and women’s health, has been named chair of the Department of Obstetrics and Gynecology at Cedars-Sinai Medical Center.
Four years ago this month, Mary Lee was diagnosed with the most aggressive type of brain tumor – a glioblastoma multiforme. These tumors are so aggressive and resistant to treatment that median length of survival after diagnosis ranges only from 12 months to 15 months, even when surgery, radiation and chemotherapy are used. Mary underwent surgery to remove a golf ball-size tumor, had a course of radiation therapy and chemotherapy, and enrolled in a clinical trial of an experimental vaccine developed at Cedars-Sinai that is designed to help prevent malignant brain tumors from recurring. Today, four years later, she continues to do well and has a new outlook on life. “You look at life differently. Every day is a good day. You’re happy to wake up. And you know that there are a lot of things that you need to get done.”
Cardiac imaging researchers at Cedars-Sinai Heart Institute are recommending that physicians not overlook fatty deposits around the heart when evaluating patients for risk of major heart problems.
Michele Tagliati, M.D., director of the Movement Disorders Program at Cedars-Sinai Medical Center, will be the keynote speaker at a special, free conference for Parkinson’s Disease patients, their families and caregivers. Titled, “Parkinson’s Disease: Promising Developments in Management and Treatment,” the conference will be held Saturday, Oct. 16, from 1-4 p.m. in the Harvey Morse Auditorium at Cedars-Sinai.
The College of American Pathologists has honored Mahul B. Amin, M.D., FCAP, chairman of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center, with two awards for outstanding leadership and contributions in the field of pathology.
Michele Tagliati, M.D., one of the nation’s leading research and treatment specialists in Parkinson’s disease and other movement disorders, has been named director of the Movement Disorders Program at Cedars-Sinai Medical Center.Tagliati is one of the pioneers and top educators of deep brain stimulation (DBS).
Researchers in Cedars-Sinai’s Department of Psychiatry and Behavioral Neurosciences have reported people who undergo massage experience measureable changes in their body’s immune and endocrine response. Although there have been previous, smaller studies about the health benefits of massage, the Cedars-Sinai study is widely believed to be the first systematic study of a larger group of healthy adults.
The Cedars-Sinai Heart Institute has opened an innovative 30-bed in-patient unit dedicated to providing advanced heart failure patients with an intensive, multidisciplinary approach to inpatient care.
Understanding the underlying genetic weakness of certain types of cancer may lead to targeted therapy and provide the key to effective treatment, a new study suggests. An international consortium of researchers has shown that an investigational drug, Olaparib, can reduce the size of tumors in women with advanced hereditary ovarian cancer with BRCA gene mutations.
Shlomo Melmed, M.D., senior vice president for academic affairs and dean of the medical faculty at Cedars-Sinai Medical Center, has been appointed by Gov. Arnold Schwarzenegger to the Independent Citizen’s Oversight Committee, the governing board of the California Institute for Regenerative Medicine.
Cedars-Sinai Medical Center has been selected as one of the top work environments for technology specialists in the United States by Computerworld, a leading national publication devoted to information technology.
Cedars-Sinai Medical Center has received its third consecutive full accreditation from the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP), whose goal is to ensure that research institutions meet the highest standards in respecting and protecting individuals who participate in research. This is done through a rigorous review process that accredits only those organizations that rigorously demonstrate tangible evidence—through policies, procedures, and practices—of their commitment to scientifically and ethically safe and sound research, and to continuous improvement.
A new system that utilizes a precise a GPS-like system to track prostate cancer tumors is now being offered to patients undergoing radiation therapy at Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute. The monitoring system, called Calypso, allows radiation beams to more precisely target the cancer as it gives real-time positioning information that allows the radiation beams to focus directly on the cancer.
Robert Figlin, M.D., F.A.C.P., a national leader in cancer research and treatment, has joined Cedars-Sinai Medical Center’s Samuel Oschin Comprehensive Cancer Institute as director of the Division of Hematology/Oncology and as associate director of the institute’s Academic Development Program.
The Cedars-Sinai Heart Institute has been awarded a $1.66 million, four-year grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to develop a measurement system that could help doctors predict which patients could be struck by sudden cardiac arrest, a heart rhythm disturbance that causes instant death in more than 95 percent of cases.
Scientists at Cedars-Sinai Medical Center have discovered characteristic amyloid plaques in retinas from Alzheimer’s disease patients and used a noninvasive optical imaging technique to detect retinal plaques in live laboratory mice, suggesting the possibility of early noninvasive diagnosis of Alzheimer’s disease.
A team of Cedars-Sinai Regenerative Medicine Institute researchers led by Terrence Town, Ph.D. has been awarded a three-year, $1.47 million grant from the California Institute for Regenerative Medicine to fund research into mechanisms for how human immune systems reject or accept transplanted brain stem cells.
Cedars-Sinai Medical Group (CSMG) and Cedars-Sinai Health Associates (CSHA) have been awarded Elite status, the highest possible designation for quality care recognized by the California Association of Physician Groups (CAPG), a professional organization comprised of the state’s leading managed care groups. Both organizations are ranked among the top 25 physician organizations in the state in 2010.
A public charter school in New York City’s Harlem neighborhood hosted the June 7 presentation of the seventh annual Pauletta and Denzel Washington Family Gifted Scholars Program in Neuroscience awards. Founded by Deborah Kenny, Ph.D., in 2001, Harlem Village Academies gained national acclaim for turning at-risk students into college-bound scholars.
A public charter school in New York City’s Harlem neighborhood will host the June 7 presentation of the seventh annual Pauletta and Denzel Washington Family Gifted Scholars in Neuroscience awards. Pauletta and Denzel Washington will be on hand to present the scholarship awards and are available for interviews.
World’s leading stem cell scientists to debate and discuss latest clinical trials using stem cells to treat ALS and heart attack patients. The The first Cedars-Sinai Regenerative Medicine Scientific Symposium, dedicated to furthering our ability to bring stem cell therapies from the laboratory to the patient bedside, will be held Monday, June 14. Led by Clive Svendsen, Ph.D., and Eduardo Marbán, M.D., Ph.D., the conference will highlight the most recent developments in leading-edge stem cell research and treatments for brain and heart diseases.
One of the nation’s leading neurologists, Patrick D. Lyden, M.D., has been named the Carmen and Louis Warschaw Chair in Neurology at Cedars-Sinai Medical Center. Lyden, who joined the Cedars-Sinai faculty as chairman of the Department of Neurology last July, has conducted extensive research into cerebrovascular disease and potential treatments for stroke.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right